Real-world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study.
Nies RJ, Ney S, Kindermann I, Bewarder Y, Zimmer A, Knebel F, Hahn K, Spethmann S, Luedike P, Michel L, Rassaf T, Papathanasiou M, Störk S, Cejka V, Polzin A, Voss F, Kelm M, Unsöld B, Meindl C, Paulus M, Yilmaz A, Chamling B, Morbach C, Pfister R.
Nies RJ, et al. Among authors: hahn k.
ESC Heart Fail. 2024 Nov 6. doi: 10.1002/ehf2.15126. Online ahead of print.
ESC Heart Fail. 2024.
PMID: 39505353
Free article.